Navigation Links
New technology to improve early detection and prognosis of cancer
Date:3/24/2011

Grand Rapids, Mich. (March 24, 2011) Gentel Biosciences, a leader in proteomics tools, and Van Andel Research Institute (VARI), a biomedical research institute, jointly announce today the granting of U.S. Patent 7,838,634 for a new method to profile changes in the glycosylation of proteins captured on the surface of an antibody array slide. Gentel first obtained an exclusive right to commercialize the technology in 2006.

According to Brian H. Haab, Ph.D., head of VARI's Laboratory of Cancer Immunodiagnostics and inventor of the technology, "A number of new biomarkers using glycosylated variants of proteins have recently received or are proceeding toward FDA clearance. The ability to efficiently screen glycosylated variants of many proteins for use as biomarkers offers an unprecedented opportunity for discoveries of new glycan-based biomarkers."

Glycosylation is the addition of linear or branched sugar molecules to proteins. Many studies have shown that glycosylated variants of proteins can make better markers for early detection and for prognosis in cancers like hepatocellular carcinoma when compared to measuring the protein alone.

"There is a lack of tools to screen proteins for changes in glycosylation that might be associated with disease. Dr. Haab's approach is a better method to identify new diagnostic biomarkers based on glycosylated variants of proteins," added Bryce P. Nelson, Ph.D., Vice President of Technology and Business Development at Gentel Biosciences.

A patent for the technology is also pending in the European Union.

The new glycan detection technology will soon be combined with the more than fifty SilverQuant Antibody Array kits available from Gentel. These antibody array kits target nearly 500 proteins and provide a complete proteomics workflow from screening to quantification. SilverQuant kits are configured for use with the Gentel Proteomics Multi-System and Gentel's AthenaQuant analysis software for an easy-to-use and cost-effective alternative with better sensitivity than fluorescence-based detection. SilverQuant chromogenic technology allows for the detection of any biotinylated molecule, generating array spots that are visible to the naked eye that can be detected with the Gentel Proteomics Multi-System. Simple protocols empower both experts and novices to obtain meaningful protein multiplexing data in a single day.


'/>"/>

Contact: Joe Gavan
joe.gavan@vai.org
616-234-5390
Van Andel Research Institute
Source:Eurekalert

Related biology news :

1. U of M researchers close in on technology for making renewable petroleum
2. University of Houston wins $1 million EPA grant to test diesel technology on buses
3. AMIA on meaningful use: Invest in people and technology
4. Cleveland Clinic researchers honored for contributions to science and technology
5. DHS Science and Technology Directorates science conference: Catastrophes and Complex Systems
6. NextCAT secures license agreement for advanced biofuel technology from Wayne State
7. New technology pinpoints genetic differences between cancer and non-cancer patients
8. Groundbreaking technology will revolutionize blood pressure measurement
9. Stanford researchers develop new technology for cheaper, more efficient solar cells
10. Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award
11. New MegaMatcher 4.0 from Neurotechnology Integrates Fingerprint, Iris, Facial and Palmprint Biometrics In One High-Performance SDK
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... PUNE, India , January 12, 2017 A new report ... 2022," projects that the global biometric technology market is expected to generate revenue of ... Continue Reading ... Allied ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:1/6/2017)... Jan. 6, 2017  Privately-held CalciMedica, Inc., announced ... healthy volunteers of a novel calcium release-activated calcium ... pancreatitis. Acute pancreatitis, sudden painful ... disorder, but can be very serious.  In severe cases ... where extended hospital stays, time in the ICU ...
(Date:1/4/2017)... Jan. 4, 2017  For the thousands of attendees at this year,s ... in connected health and biometric measurement devices and services, will be featuring ... On display in A&D Medical,s special CES Exhibit Suite , the ... expansion of the company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Jan. 18, 2017 Acupath Laboratories, Inc., a ... formation of an Executive Committee that will guide the ... John Cucci , a 15-year veteran of ... of Business Development to Chief Sales Officer .  ... served in senior sales leadership roles at several leading ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... provide essential device-to-computer interconnect using USB or PCI Express, announced the ZEM5310 USB ... V E FPGA into a compact business-card sized form factor suitable for prototyping, ...
(Date:1/18/2017)...   Boston Biomedical , an industry leader in ... stemness pathways, will feature data from two clinical studies ... ASCO Gastrointestinal Cancers Symposium, held from January 19-21, in ... Napabucasin is an orally-administered investigational agent designed to inhibit ... stem cells (CSCs) possess the property of stemness – ...
(Date:1/18/2017)... HACKENSACK, N.J. , Jan. 18, 2017   ... leading the fight to end Duchenne muscular dystrophy ... awarded to the New Jersey Institute of Technology (NJIT) ... ongoing exploration of robotic technology to assist ... study to incorporate NJIT,s technology – an embedded computer, ...
Breaking Biology Technology: